Eleanor Barnes

Eleanor Barnes is a British physician at the John Radcliffe Hospital and a Professor of Hepatology and Experimental Medicine at the University of Oxford. She has studied hepatitis C and the development of the development of HCV vaccines. She is a Fellow of the Academy of Medical Sciences and serves as the lead for hepatology at the National Institute for Health Research (NIHR) Clinical Research Network. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'Eleanor Barnes', query time: 0.04s Refine Results
  1. 1
    Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”

    Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment” by Philippa C. Matthews, Tingyan Wang, Eleanor Barnes

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosing Cholangitis and Its Relevance for Targeting B Cell Pathways in Disease

    The Differential Complement, Fc and Chemokine Receptor Expression of B Cells in IgG4-Related Pancreatobiliary Disease and Primary Sclerosing Cholangitis and Its Relevance for Targe... by Tamsin Cargill, Eleanor Barnes, Theo Rispens, Emma L. Culver

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prospective cohort for early detection of liver cancer (Pearl): a study protocol

    Prospective cohort for early detection of liver cancer (Pearl): a study protocol by Emma Culver, Eleanor Barnes, Michael Pavlides, Hamish Innes, Jennifer Benselin, William Irving, Kartikeya Khanna, DeLIVER Consortium

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study

    SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study by Eleanor Barnes, David Eyre, Katie Jeffery, Jia Wei, Victoria Ward, William Gordon, Susie Dunachie, Anne-Marie O’Donnell

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.

    Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study. by Bevin Gangadharan, Manisha Bapat, Jan Rossa, Robin Antrobus, David Chittenden, Bettina Kampa, Eleanor Barnes, Paul Klenerman, Raymond A Dwek, Nicole Zitzmann

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure.

    Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure. by Lele Zhao, Matthew Hall, Prahalad Giridhar, Mahan Ghafari, Steven Kemp, Haiting Chai, Paul Klenerman, Eleanor Barnes, M Azim Ansari, Katrina Lythgoe

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati.

    Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. by G L Abby Harrison, Jan Pryor, Joji Malani, Mathias Supuri, Andrew Masta, Burentau Teriboriki, Tebuka Toatu, David Penny, Jean-Pierre Allain, Eleanor Barnes, Oliver G Pybus, Paul Klenerman

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial

    Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a m... by Ernest Choy, Kerenza Hood, Emma Thomas-Jones, Eleanor Barnes, Keith Wilson, Christian H Ottensmeier, Debbie Harris, Adrian Hill, Mark Tuthill, Richard Adams, Catherine Porter, Katie Ewer, Sian Griffin, Rebecca Tangney, Joanne Euden, Shirley Pringle, Lawrence Raisanen, Ruby Ray, Lisette Sheena Nixon, Melanie Varley, Craig Bodman, Paola Cicconi, Vivien Dagley, Steven Knapper

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples.

    A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samples. by Elizabeth M Batty, T H Nicholas Wong, Amy Trebes, Karène Argoud, Moustafa Attar, David Buck, Camilla L C Ip, Tanya Golubchik, Madeleine Cule, Rory Bowden, Charis Manganis, Paul Klenerman, Eleanor Barnes, A Sarah Walker, David H Wyllie, Daniel J Wilson, Kate E Dingle, Tim E A Peto, Derrick W Crook, Paolo Piazza

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.

    Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus. by Aminata Sy, Leanne McCabe, Emma Hudson, Azim M Ansari, Vincent Pedergnana, Shang-Kuan Lin, S Santana, Marzia Fiorino, Aftab Ala, Ben Stone, M Smith, Mark Nelson, Stephen T Barclay, Stuart McPherson, Stephen D Ryder, Jane Collier, Eleanor Barnes, Ann Sarah Walker, Sarah L Pett, Graham Cooke, STOP-HCV-1 trial team

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

    Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study by Valeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, Michael Praktiknjo, Edilmar Alvarado-Tapias, Laura Turco, Luis Ibáñez-Samaniego, Carlos González-Alayón, Ángela Puente, Elba Llop, Macarena Simón-Talero, Carmen Álvarez-Navascués, Thomas Reiberger, Xavier Verhelst, Luis Tellez, Johanna Birte Bergmann, Lara Orts, Giuseppe Grassi, Anna Baiges, Payance Audrey, Jonel Trebicka, Candid Villanueva, Maria Cristina Morelli, Sam Murray, Georgina Meacham, Marc Luetgehetmann, Julian Schulze zur Wiesch, Juan-Carlos García-Pagán, Eleanor Barnes, Aurélie Plessier, Virginia Hernández-Gea

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms

    Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms by Sheila F. Lumley, Chris Kent, Daisy Jennings, Haiting Chai, George Airey, Elizabeth Waddilove, Marion Delphin, Amy Trebes, Anna L. McNaughton, Khadija Said Mohammed, Sam A. J. Wilkinson, Yanxia Wu, George MacIntyre-Cockett, Beatrice Kimono, Kwizera Moses Mbonye, Kevin Ojambo, Tongai G. Maponga, Cedric C. S. Tan, Catherine de Lara, Jacqueline Martin, James Campbell, Marije Van Schalkwyk, Dominique Goedhals, Robert Newton, Eleanor Barnes, Nicholas J. Loman, Paolo Piazza, Joshua Quick, M. Azim Ansari, Philippa C. Matthews

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy

    Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy by Tingyan Wang, Cori Campbell, Alexander J. Stockdale, Stacy Todd, Karl McIntyre, Andrew Frankland, Jakub Jaworski, Ben Glampson, Dimitri Papadimitriou, Luca Mercuri, Erik Mayer, Christopher R. Jones, Hizni Salih, Gail Roadknight, Stephanie Little, Theresa Noble, Kinga A. Várnai, Cai Davis, Ashley I. Heinson, Michael George, Florina Borca, Louise English, Luis Romão, David Ramlakhan, Kerrie Woods, Jim Davies, Eleni Nastouli, Salim I. Khakoo, William Gelson, Graham S. Cooke, Eleanor Barnes, Philippa C. Matthews, Eleanor Barnes, Philippa C. Matthews, William Gelson, Graham S. Cooke, Salim I. Khakoo, Eleni Nastouli, Jim Davies, Kerrie Woods, Alexander J. Stockdale, Stephen Ryder, Ahmed Elsharkawy, Nicholas Easom, William Bernal, Shazaad Ahmad, Douglas Macdonald, Tingyan Wang, Cori Campbell, Simon Stanworth, Suzanne Maynard, Gail Roadknight, Stephanie Little, Kinga A. Várnai, Ben Glampson, Dimitri Papadimitriou, Luca Mercuri, Christopher R. Jones, Jakub Jaworski, Cai Davis, Florina Borca, Ashley Heinson, Michael George, Heidi MacNaughton, Yun Kim, Josune Olza Meneses, Louise English, Timothy Roberts, Luis Romão, David Ramlakhan, Stacy Todd, Heather Rogers, Karl McIntyre, Andrew Frankland, Hizni Salih, Theresa Noble, Lara Roberts, Finola Higgins, Javier Vilar, Ruth Norris, George Tilston, Ilina Serafimova, Sarah Montague, Juliette Verheyden, Irene Juurlink, Kathryn Jack, Alex Waldren-Glenn, Lizzie Poole, Victoria Day, Berit Reglar

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.

    Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. by Jonathan Youngs, Nicholas M Provine, Nicholas Lim, Hannah R Sharpe, Ali Amini, Yi-Ling Chen, Jian Luo, Matthew D Edmans, Panagiota Zacharopoulou, Wentao Chen, Oliver Sampson, Robert Paton, William J Hurt, David A Duncan, Anna L McNaughton, Vincent N Miao, Susannah Leaver, Duncan L A Wyncoll, Jonathan Ball, Philip Hopkins, Oxford Immunology Network Covid-19 response T cell Consortium, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Donal T Skelly, Eleanor Barnes, Susanna Dunachie, Graham Ogg, Teresa Lambe, Ian Pavord, Alex K Shalek, Craig P Thompson, Luzheng Xue, Derek C Macallan, Philip Goulder, Paul Klenerman, Tihana Bicanic

    Published 2021-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: